ArticleTropical animal health and production2023
Seasonal distribution of repeat breeder cows and evaluation of modified protocols for post AI treatment during summer.
Article in Tropical animal health and production, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An important problem of dairy industry worldwide is repeat breeder cows (RB). In this study, one farm in Northern Greece was chosen on the basis of subfertility. First, the available reproductive data of the previous year were evaluated; then, the farmer was advised to use the most common treatments for RB [GnRH with the third artificial insemination (AI+GnRH) or ovsynch in cows found empty after the second AI], and their efficacy was monitored throughout the year. Cows (n = 147) 2.5 to 4.5 years old were included. During the next year, post AI treatments (meta-ovsynch and meta-AI) were used during summer; GnRH (100 μg of gonadorelin) alone or in combination with meloxicam (0.5 mg/kg BW) was used during summer. Meta-ovsynch protocols were administered to 29 cows detected as non-pregnant after 3 AIs; cows were divided randomly into 3 meta-ovsynch (OS) groups: group OS (controls, n = 10), standard ovsynch protocol; group OS+GnRH (n = 10), OS plus GnRH 10 days after AI; and group OS+GnRH+NSAID (n = 9), OS plus GnRH 10 days after AI plus meloxicam 15 days after AI. Meta-AI protocols were tested in 27 RB cows; cows were divided randomly into 3 AI groups: GnRH (n = 9), 1 dose of GnRH with AI; GnRH-GnRH (n = 9), two doses of GnRH, one with AI and another 10 days later; and GnRH-GnRH-NSAID (n = 9), two doses of GnRH as in GnRH-GnRH group and one dose of meloxicam 15 days after AI. Pregnancy diagnosis was performed by ultrasound 38 days after AI. During the 1st year of evaluation, 53.79% of cows had received ≥ 3 AIs; the highest percentage (38.48%) of RB cows was recorded during autumn. After treatment for RB, the lowest (P < 0.05) pregnancy rate (PR) was recorded in August (18.18%) compared to January (75.0%), May (53.33%), and December (50.0%, P < 0.1). The efficacy of ovsynch during winter was significantly higher compared to all the other seasons. The percentage of cows with increased estrous cycle duration (24-37 days) after RB treatment and AI was the highest (P < 0.05) in spring and summer after AI+GnRH and the lowest (P < 0.05) during winter after ovsynch. Concerning the post AI treatments during summer, significantly higher pregnancy rate was recorded in the OS+GnRH+NSAID group (55.55%) compared to OS+GnRH (10%) and OS (10%) groups. Pregnancy rates did not differ among AI groups. It seems that OS+GnRH+NSAID is a promising protocol for RB cows during summer although further research is needed to support the present results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.